Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Stealth BioTherapeutics stock | $1.15

Learn how to easily invest in Stealth BioTherapeutics stock.

Stealth BioTherapeutics Corp is a biotechnology business based in the US. Stealth BioTherapeutics shares (MITO) are listed on the NASDAQ and all prices are listed in US Dollars. Stealth BioTherapeutics employs 29 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Stealth BioTherapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MITO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Stealth BioTherapeutics stock price (NASDAQ: MITO)

Use our graph to track the performance of MITO stocks over time.

Stealth BioTherapeutics shares at a glance

Information last updated 2021-10-23.
Latest market close$1.15
52-week range$1.06 - $2.48
50-day moving average $1.37
200-day moving average $1.37
Wall St. target price$3.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.05

Buy Stealth BioTherapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Stealth BioTherapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Stealth BioTherapeutics price performance over time

Historical closes compared with the close of $1.15 from 2021-10-26

1 week (2021-10-20) -8.73%
1 month (2021-09-27) -18.44%
3 months (2021-07-27) -14.81%
6 months (2021-04-27) -8.00%
1 year (2020-10-27) -24.14%
2 years (2019-10-25) -81.80%
3 years (2018-10-23) N/A
5 years (2016-10-23) N/A

Stealth BioTherapeutics financials

Revenue TTM $21.1 million
Gross profit TTM $21.1 million
Return on assets TTM -83.02%
Return on equity TTM -1666.63%
Profit margin 0%
Book value $0.05
Market capitalisation $67.9 million

TTM: trailing 12 months

Shorting Stealth BioTherapeutics shares

There are currently 1.1 million Stealth BioTherapeutics shares held short by investors – that's known as Stealth BioTherapeutics's "short interest". This figure is 29.8% up from 853,165 last month.

There are a few different ways that this level of interest in shorting Stealth BioTherapeutics shares can be evaluated.

Stealth BioTherapeutics's "short interest ratio" (SIR)

Stealth BioTherapeutics's "short interest ratio" (SIR) is the quantity of Stealth BioTherapeutics shares currently shorted divided by the average quantity of Stealth BioTherapeutics shares traded daily (recently around 483665.50218341). Stealth BioTherapeutics's SIR currently stands at 2.29. In other words for every 100,000 Stealth BioTherapeutics shares traded daily on the market, roughly 2290 shares are currently held short.

However Stealth BioTherapeutics's short interest can also be evaluated against the total number of Stealth BioTherapeutics shares, or, against the total number of tradable Stealth BioTherapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Stealth BioTherapeutics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Stealth BioTherapeutics shares in existence, roughly 20 shares are currently held short) or 0.0494% of the tradable shares (for every 100,000 tradable Stealth BioTherapeutics shares, roughly 49 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Stealth BioTherapeutics.

Find out more about how you can short Stealth BioTherapeutics stock.

Stealth BioTherapeutics share dividends

We're not expecting Stealth BioTherapeutics to pay a dividend over the next 12 months.

Stealth BioTherapeutics share price volatility

Over the last 12 months, Stealth BioTherapeutics's shares have ranged in value from as little as $1.06 up to $2.48. A popular way to gauge a stock's volatility is its "beta".

MITO.US volatility(beta: 1.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Stealth BioTherapeutics's is 1.8838. This would suggest that Stealth BioTherapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Stealth BioTherapeutics overview

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duchenne cardiomyopathy, phase 2a clinical trial to treat friedreich's ataxia, phase 2 clinical trial for the treatment of dry age-related macular degeneration, phase 2 clinical trial to treat leber's hereditary optic neuropathy, and phase 3 clinical trial for the treatment of replisome myopathies. The company's product candidates also include SBT-20 to treat complications of diabetes, renal diseases, ocular diseases, neurodegenerative, Parkinson's, Alzheimer's, Huntington's, and ALS diseases; SBT-550 for rare neurological indications; and SBT-272, a peptidomimetic that targets the mitochondria and stabilizing mitochondrial function under conditions of oxidative stress, as well as SBT 550. Stealth BioTherapeutics Corp was incorporated in 2006 and is based in George Town, the Cayman Islands. .

Frequently asked questions

What percentage of Stealth BioTherapeutics is owned by institutions?
Currently 10.233% of Stealth BioTherapeutics shares are held by institutions.
How many people work for Stealth BioTherapeutics?
Latest data suggests 29 work at Stealth BioTherapeutics.
When does the fiscal year end for Stealth BioTherapeutics?
Stealth BioTherapeutics's fiscal year ends in December.
Where is Stealth BioTherapeutics based?
Stealth BioTherapeutics's address is: 190 Elgin Avenue, George Town, Cayman Islands, KY1-9005
What is Stealth BioTherapeutics's ISIN number?
Stealth BioTherapeutics's international securities identification number is: US85789A1051
What is Stealth BioTherapeutics's CUSIP number?
Stealth BioTherapeutics's Committee on Uniform Securities Identification Procedures number is: 85789A105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site